The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Although the Company’s efforts to identify a prospective business combination opportunity will not be limited to a particular industry, it intends to focus on healthcare or healthcare-related companies in Asian markets with a focus on the Greater China market, or global healthcare or healthcare-related companies with a meaningful growth thesis in the Greater China or Asian markets, which can benefit from the expertise and capabilities of our management team in order to create long-term shareholder value.
Company profile
Ticker
HHLA, HHLA.UN
Exchange
Employees
Location
Fiscal year end
Industry (SIC)
SEC CIK
HHLA stock data
Latest filings (excl ownership)
25-NSE
Exchange delisting
23 Feb 24
8-K
Other Events
7 Feb 24
PRE 14A
Preliminary proxy
23 Jan 24
10-Q
2023 Q3
Quarterly report
20 Nov 23
NT 10-Q
Notice of late quarterly filing
14 Nov 23
RW
Registration withdrawal request
3 Nov 23
8-K
Entry into a Material Definitive Agreement
28 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
Amendments to Articles of Incorporation or Bylaws
10 Aug 23
8-K
Entry into a Material Definitive Agreement
9 Aug 23
Latest ownership filings
SC 13G
FIR TREE CAPITAL MANAGEMENT LP
14 Feb 24
SC 13G
MIZUHO FINANCIAL GROUP INC
13 Feb 24
SC 13G/A
ARISTEIA CAPITAL, L.L.C.
12 Feb 24
SC 13G
PERISCOPE CAPITAL INC.
9 Feb 24
SC 13G
K2 PRINCIPAL FUND, L.P.
9 Feb 24
SC 13G/A
JPMORGAN CHASE & CO
8 Feb 24
SC 13G/A
HIGHBRIDGE CAPITAL MANAGEMENT LLC
7 Feb 24
SC 13G
JPMORGAN CHASE & CO
6 Feb 24
SC 13G
Harraden Circle Investments, LLC
31 Jan 24
4
Change in insider ownership
12 Jan 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 123.33 k | 123.33 k | 123.33 k | 123.33 k | 123.33 k | 123.33 k |
Cash burn (monthly) | 1.22 k | 14.15 k | 1.53 mm | 663.94 k | 113.72 k | 66.44 k |
Cash used (since last report) | 8.36 k | 96.89 k | 10.48 mm | 4.55 mm | 778.69 k | 454.95 k |
Cash remaining | 114.98 k | 26.44 k | -10.36 mm | -4.42 mm | -655.35 k | -331.62 k |
Runway (months of cash) | 94.2 | 1.9 | -6.8 | -6.7 | -5.8 | -5.0 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 60 |
Opened positions | 3 |
Closed positions | 12 |
Increased positions | 7 |
Reduced positions | 16 |
13F shares | Current |
---|---|
Total value | 55.60 bn |
Total shares | 18.40 mm |
Total puts | 0.00 |
Total calls | 1.13 mm |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
D. E. Shaw & Co | 1.30 mm | $0.00 |
Periscope Capital | 1.14 mm | $4.61 bn |
Meteora Capital | 1.00 mm | $3.15 bn |
Aristeia Capital | 953.90 k | $19.27 mm |
Ionic Capital Management | 952.74 k | $19.06 mm |
Radcliffe Capital Management | 867.43 k | $5.25 bn |
MY.Alpha Management HK Advisors | 864.20 k | $17.00 mm |
Westchester Capital Management | 831.69 k | $8.71 bn |
Athos Capital | 806.35 k | $8.45 mm |
Glazer Capital | 750.00 k | $7.85 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Jan 24 | Highbridge Capital Management | Class A Ordinary Shares, par value $0.0001 per share | Sell | Dispose S | Yes | No | 10.75 | 250,000 | 2.69 mm | 250,000 |